MERCINELLI, CHIARA
MERCINELLI, CHIARA
Facoltà di Medicina e Chirurgia
Addition of androgen-receptor pathway inhibitors to standard of care in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
2026-01-01 Maiorano, Brigida Anna; Mercinelli, Chiara; Cigliola, Antonio; Tateo, Valentina; Gandaglia, Giorgio; Briganti, Alberto; Montorsi, Francesco; Necchi, Andrea
Adjuvant pembrolizumab plus belzutifan versus placebo in clear cell renal cell carcinoma: a reconstructed survival data analysis of the KEYNOTE-564 and the LITESPARK-022 trials
2026-01-01 Cigliola, A.; Larcher, A.; Maiorano, B. A.; Robesti, D.; Fallara, G.; Mercinelli, C.; Re, C.; Musso, G.; Cei, F.; Tateo, V.; Piacentini, M.; Bertini, A.; Disabato, N.; Piccolo, C.; Rosiello, G.; Briganti, A.; Necchi, A.; Montorsi, F.; Martini, A.; Capitanio, U.
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy
2026-01-01 Necchi, A.; Brembilla, G.; Whiting, K.; Arita, Y.; Akin, O.; Apte, A.; Awais, M.; Lema-Dopico, A.; Paudyal, R.; Cosenza, M.; Maiorano, B. A.; Tateo, V.; Cigliola, A.; Mercinelli, C.; De Cobelli, F.; Capanu, M.; Shukla-Dave, A.; Schwartz, L. H.
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis
2026-01-01 Di Costanzo, Fabrizio; Mercinelli, Chiara; Signori, Alessio; Messina, Carlo; Conteduca, Vincenza; Dima, Giovanni; Santoni, Matteo; Formisano, Luigi; Oing, Christoph; Fornarini, Giuseppe; Rebuzzi, Sara Elena; Caffo, Orazio; Banna, Giuseppe Luigi; De Giorgi, Ugo; Procopio, Giuseppe; Montorsi, Francesco; Briganti, Alberto; Galli, Luca; Di Maio, Massimo; Necchi, Andrea; Maiorano, Brigida Anna; Rescigno, Pasquale
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer
2024-01-01 Li, R.; Nocera, L.; Rose, K. M.; Raggi, D.; Naidu, S.; Mercinelli, C.; Cigliola, A.; Tateo, V.; Patane, D.; Grass, G. D.; Gilbert, S. M.; Sexton, W. J.; Bandini, M.; Moschini, M.; Briganti, A.; Montorsi, F.; Spiess, P. E.; Necchi, A.
Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials
2026-01-01 Maiorano, B. A.; Maruzzo, M.; Slusarczyk, A.; Subiela, J. D.; Soria, F.; Albisinni, S.; Mari, A.; Claps, F.; Contieri, R.; Gallioli, A.; Cano-Velasco, J.; D'Andrea, D.; Laukhtina, E.; Marcq, G.; Krajewski, W.; Grobet-Jeandin, E.; Afferi, L.; Del Giudice, F.; Rizzo, A.; Moschini, M.; Mertens, L. S.; Cigliola, A.; Mercinelli, C.; Piacentini, M.; Santoni, M.; Pradere, B.; Necchi, A.
Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatinbased chemotherapy before radical cystectomy (RC)
2024-01-01 Mercinelli, C.; Raggi, D.; Cigliola, A.; Tateo, V.; Patane, D. A.; Crupi, E.; Colecchia, M.; Moschini, M.; Re, C.; Avesani, G.; Briganti, A.; Montorsi, F.; Ross, J. S.; Graf, R.; Pavlick, D. C.; Necchi, A.
Corrigendum to “Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials”(European Urology, (2025), (S0302283825048778), 10.1016/j.eururo.2025.12.022)
2026-01-01 Scilipoti, P.; Zaurito, P.; Longoni, M.; Colecchia, M.; Montorsi, F.; Salonia, A.; Mercinelli, C.; Maiorano, B.; Necchi, A.; Briganti, A.; Moschini, M.
Data from Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
2025-01-01 Tateo, Valentina; De Jong, Joep J.; Cigliola, Antonio; Maiorano, Brigida A.; Mercinelli, Chiara; Crupi, Emanuele; Giannatempo, Patrizia; Colecchia, Maurizio; Moschini, Marco; Proudfoot, James A.; Santini, Daniele; Davicioni, Elai; Briganti, Alberto; Montorsi, Francesco; Necchi, Andrea
Diagnostic and treatment delays in penile cancer: a call to improve awareness and referral
2026-01-01 Negri, F.; Basile, G.; Galdieri, A.; Longoni, M.; Raffo, M.; Pozzi, E.; Belladelli, F.; Folcia, A.; Malvestiti, M.; Mercinelli, C.; Necchi, A.; Colecchia, M.; Briganti, A.; Montorsi, F.; Salonia, A.; Bandini, M.
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study
2024-01-01 Reike, M. J.; Raggi, D.; Mercinelli, C.; Cigliola, A.; Tateo, V.; Patanè, D. A.; Crupi, E.; De Padua, T. C.; Black, P. C.; Gibb, E. A.; Necchi, A.
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials
2026-01-01 Scilipoti, P.; Zaurito, P.; Longoni, M.; Colecchia, M.; Montorsi, F.; Salonia, A.; Mercinelli, C.; Maiorano, B.; Necchi, A.; Briganti, A.; Moschini, M.
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC)
2024-01-01 Mercinelli, C.; Basile, G.; Raggi, D.; Cigliola, A.; Tateo, V.; Patanè, D. A.; Crupi, E.; Padua, T. C. D.; Colecchia, M.; Colombo, R.; Moschini, M.; Re, C.; Avesani, G.; Brembilla, G.; De Cobelli, F.; Briganti, A.; Pavlick, D. C.; Ross, J. S.; Montorsi, F.; Necchi, A.
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer
2024-01-01 Mercinelli, C.; Moschini, M.; Cigliola, A.; Mattorre, B.; Tateo, V.; Basile, G.; Cogrossi, L. L.; Maiorano, B. A.; Patane, D. A.; Raggi, D.; Pastorino, G. L.; Re, C.; Colecchia, M.; Luciano, R.; Colombo, R.; Brembilla, G.; De Cobelli, F.; Briganti, A.; Pavlick, D. C.; Ross, J. S.; Montorsi, F.; Bellone, M.; Necchi, A.
Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy
2026-01-01 Mercinelli, C.; Pavlick, D.; Agarwal, N.; Spiess, P. E.; Li, R.; Kamat, A. M.; Grivas, P.; Gupta, S.; Maiorano, B. A.; Tateo, V.; Cigliola, A.; Piacentini, M.; Jacob, J. M.; Bratslavsky, G.; Basnet, A.; Ross, J. S.; Necchi, A.
Immune-based Therapies for Penile Cancer
2024-01-01 Al Assaad, M.; Safa, H.; Mercinelli, C.; Spiess, P. E.; Necchi, A.; Chahoud, J.
Immunotherapy toxicities in genito-urinary cancers: insights and challenges for clinicians
2025-01-01 Mercinelli, C.; Carli, C.; Di Vita, R.; Oliveri, M.; Galli, L.; Necchi, A.
Impact of Age on Outcomes in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT)
2026-01-01 Cigliola, Antonio; Dizman, Nazli; Mercinelli, Chiara; Zhu, Yao; Carlo, Maria I; Psutka, Sarah P; Berg, Stephanie A; Prakash, Gagan; Aragon-Ching, Jeanny B; Oualla, Karima; Linville, Laura Meili; Nguyen, Charles B; Yip, Wesley; Maiorano, Brigida Anna; Tateo, Valentina; Spiess, Philippe E; Pal, Sumanta Kumar; Necchi, Andrea
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility
2025-01-01 Scilipoti, P.; Rosiello, G.; Longoni, M.; Bettiga, A.; Re, C.; Musso, G.; Cei, F.; Salerno, L.; Belladelli, F.; Karakiewicz, P. I.; Mottrie, A.; Briganti, A.; Salonia, A.; Mercinelli, C.; Cigliola, A.; Necchi, A.; Trevisani, F.; Montorsi, F.; Larcher, A.; Capitanio, U.
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
2025-01-01 Tateo, V.; De Jong, J. J.; Cigliola, A.; Maiorano, B. A.; Mercinelli, C.; Crupi, E.; Giannatempo, P.; Colecchia, M.; Moschini, M.; Proudfoot, J. A.; Santini, D.; Davicioni, E.; Briganti, A.; Montorsi, F.; Necchi, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Addition of androgen-receptor pathway inhibitors to standard of care in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis | 1-gen-2026 | Maiorano, Brigida Anna; Mercinelli, Chiara; Cigliola, Antonio; Tateo, Valentina; Gandaglia, Giorgio; Briganti, Alberto; Montorsi, Francesco; Necchi, Andrea | |
| Adjuvant pembrolizumab plus belzutifan versus placebo in clear cell renal cell carcinoma: a reconstructed survival data analysis of the KEYNOTE-564 and the LITESPARK-022 trials | 1-gen-2026 | Cigliola, A.; Larcher, A.; Maiorano, B. A.; Robesti, D.; Fallara, G.; Mercinelli, C.; Re, C.; Musso, G.; Cei, F.; Tateo, V.; Piacentini, M.; Bertini, A.; Disabato, N.; Piccolo, C.; Rosiello, G.; Briganti, A.; Necchi, A.; Montorsi, F.; Martini, A.; Capitanio, U. | |
| AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy | 1-gen-2026 | Necchi, A.; Brembilla, G.; Whiting, K.; Arita, Y.; Akin, O.; Apte, A.; Awais, M.; Lema-Dopico, A.; Paudyal, R.; Cosenza, M.; Maiorano, B. A.; Tateo, V.; Cigliola, A.; Mercinelli, C.; De Cobelli, F.; Capanu, M.; Shukla-Dave, A.; Schwartz, L. H. | |
| Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis | 1-gen-2026 | Di Costanzo, Fabrizio; Mercinelli, Chiara; Signori, Alessio; Messina, Carlo; Conteduca, Vincenza; Dima, Giovanni; Santoni, Matteo; Formisano, Luigi; Oing, Christoph; Fornarini, Giuseppe; Rebuzzi, Sara Elena; Caffo, Orazio; Banna, Giuseppe Luigi; De Giorgi, Ugo; Procopio, Giuseppe; Montorsi, Francesco; Briganti, Alberto; Galli, Luca; Di Maio, Massimo; Necchi, Andrea; Maiorano, Brigida Anna; Rescigno, Pasquale | |
| Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer | 1-gen-2024 | Li, R.; Nocera, L.; Rose, K. M.; Raggi, D.; Naidu, S.; Mercinelli, C.; Cigliola, A.; Tateo, V.; Patane, D.; Grass, G. D.; Gilbert, S. M.; Sexton, W. J.; Bandini, M.; Moschini, M.; Briganti, A.; Montorsi, F.; Spiess, P. E.; Necchi, A. | |
| Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials | 1-gen-2026 | Maiorano, B. A.; Maruzzo, M.; Slusarczyk, A.; Subiela, J. D.; Soria, F.; Albisinni, S.; Mari, A.; Claps, F.; Contieri, R.; Gallioli, A.; Cano-Velasco, J.; D'Andrea, D.; Laukhtina, E.; Marcq, G.; Krajewski, W.; Grobet-Jeandin, E.; Afferi, L.; Del Giudice, F.; Rizzo, A.; Moschini, M.; Mertens, L. S.; Cigliola, A.; Mercinelli, C.; Piacentini, M.; Santoni, M.; Pradere, B.; Necchi, A. | |
| Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatinbased chemotherapy before radical cystectomy (RC) | 1-gen-2024 | Mercinelli, C.; Raggi, D.; Cigliola, A.; Tateo, V.; Patane, D. A.; Crupi, E.; Colecchia, M.; Moschini, M.; Re, C.; Avesani, G.; Briganti, A.; Montorsi, F.; Ross, J. S.; Graf, R.; Pavlick, D. C.; Necchi, A. | |
| Corrigendum to “Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials”(European Urology, (2025), (S0302283825048778), 10.1016/j.eururo.2025.12.022) | 1-gen-2026 | Scilipoti, P.; Zaurito, P.; Longoni, M.; Colecchia, M.; Montorsi, F.; Salonia, A.; Mercinelli, C.; Maiorano, B.; Necchi, A.; Briganti, A.; Moschini, M. | |
| Data from Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer | 1-gen-2025 | Tateo, Valentina; De Jong, Joep J.; Cigliola, Antonio; Maiorano, Brigida A.; Mercinelli, Chiara; Crupi, Emanuele; Giannatempo, Patrizia; Colecchia, Maurizio; Moschini, Marco; Proudfoot, James A.; Santini, Daniele; Davicioni, Elai; Briganti, Alberto; Montorsi, Francesco; Necchi, Andrea | |
| Diagnostic and treatment delays in penile cancer: a call to improve awareness and referral | 1-gen-2026 | Negri, F.; Basile, G.; Galdieri, A.; Longoni, M.; Raffo, M.; Pozzi, E.; Belladelli, F.; Folcia, A.; Malvestiti, M.; Mercinelli, C.; Necchi, A.; Colecchia, M.; Briganti, A.; Montorsi, F.; Salonia, A.; Bandini, M. | |
| Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study | 1-gen-2024 | Reike, M. J.; Raggi, D.; Mercinelli, C.; Cigliola, A.; Tateo, V.; Patanè, D. A.; Crupi, E.; De Padua, T. C.; Black, P. C.; Gibb, E. A.; Necchi, A. | |
| Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials | 1-gen-2026 | Scilipoti, P.; Zaurito, P.; Longoni, M.; Colecchia, M.; Montorsi, F.; Salonia, A.; Mercinelli, C.; Maiorano, B.; Necchi, A.; Briganti, A.; Moschini, M. | |
| First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) | 1-gen-2024 | Mercinelli, C.; Basile, G.; Raggi, D.; Cigliola, A.; Tateo, V.; Patanè, D. A.; Crupi, E.; Padua, T. C. D.; Colecchia, M.; Colombo, R.; Moschini, M.; Re, C.; Avesani, G.; Brembilla, G.; De Cobelli, F.; Briganti, A.; Pavlick, D. C.; Ross, J. S.; Montorsi, F.; Necchi, A. | |
| First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer | 1-gen-2024 | Mercinelli, C.; Moschini, M.; Cigliola, A.; Mattorre, B.; Tateo, V.; Basile, G.; Cogrossi, L. L.; Maiorano, B. A.; Patane, D. A.; Raggi, D.; Pastorino, G. L.; Re, C.; Colecchia, M.; Luciano, R.; Colombo, R.; Brembilla, G.; De Cobelli, F.; Briganti, A.; Pavlick, D. C.; Ross, J. S.; Montorsi, F.; Bellone, M.; Necchi, A. | |
| Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy | 1-gen-2026 | Mercinelli, C.; Pavlick, D.; Agarwal, N.; Spiess, P. E.; Li, R.; Kamat, A. M.; Grivas, P.; Gupta, S.; Maiorano, B. A.; Tateo, V.; Cigliola, A.; Piacentini, M.; Jacob, J. M.; Bratslavsky, G.; Basnet, A.; Ross, J. S.; Necchi, A. | |
| Immune-based Therapies for Penile Cancer | 1-gen-2024 | Al Assaad, M.; Safa, H.; Mercinelli, C.; Spiess, P. E.; Necchi, A.; Chahoud, J. | |
| Immunotherapy toxicities in genito-urinary cancers: insights and challenges for clinicians | 1-gen-2025 | Mercinelli, C.; Carli, C.; Di Vita, R.; Oliveri, M.; Galli, L.; Necchi, A. | |
| Impact of Age on Outcomes in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT) | 1-gen-2026 | Cigliola, Antonio; Dizman, Nazli; Mercinelli, Chiara; Zhu, Yao; Carlo, Maria I; Psutka, Sarah P; Berg, Stephanie A; Prakash, Gagan; Aragon-Ching, Jeanny B; Oualla, Karima; Linville, Laura Meili; Nguyen, Charles B; Yip, Wesley; Maiorano, Brigida Anna; Tateo, Valentina; Spiess, Philippe E; Pal, Sumanta Kumar; Necchi, Andrea | |
| Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility | 1-gen-2025 | Scilipoti, P.; Rosiello, G.; Longoni, M.; Bettiga, A.; Re, C.; Musso, G.; Cei, F.; Salerno, L.; Belladelli, F.; Karakiewicz, P. I.; Mottrie, A.; Briganti, A.; Salonia, A.; Mercinelli, C.; Cigliola, A.; Necchi, A.; Trevisani, F.; Montorsi, F.; Larcher, A.; Capitanio, U. | |
| Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer | 1-gen-2025 | Tateo, V.; De Jong, J. J.; Cigliola, A.; Maiorano, B. A.; Mercinelli, C.; Crupi, E.; Giannatempo, P.; Colecchia, M.; Moschini, M.; Proudfoot, J. A.; Santini, D.; Davicioni, E.; Briganti, A.; Montorsi, F.; Necchi, A. |